Skip to main content
logo
Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
170.10
+1.50 (0.89%)
Oct 21, 2026, 2:45 PM HKT

Duality Biotherapeutics Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
842.131,8521,9411,7871.6
Revenue Growth
-54.52%-4.61%8.66%111558.75%-
Gross Profit
-233.67589.09784.671,3591.6
Operating Income
-1,494-460.12-187.04736.27-370.15
Net Income
-1,439-2,595-1,050-357.51-387.09
Earnings Per Share
-16.09-39.82-131.30-44.69-48.39
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
3,0433,3801,3971,136379.14
Total Debt
379.46149.785.295.324.67
Net Cash (Debt)
2,6633,2301,3921,131374.47
Net Cash Growth
-17.56%132.13%23.07%201.98%-
Net Cash Per Share
29.7849.58173.96141.3546.81

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-818.88194.58285.78816.34-299.47
Capital Expenditures
-14.34-11.5-4.08-11.28-2.48
Free Cash Flow
-833.23183.08281.7805.05-301.95
Free Cash Flow Growth
--35.01%-65.01%--

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
-27.75%31.81%40.42%76.06%100.00%
Operating Margin
-177.37%-24.85%-9.63%41.21%-23134.25%
Pretax Margin
-170.82%-140.13%-52.26%-11.32%-24193.13%
Profit Margin
-170.82%-140.13%-54.11%-20.01%-24193.13%
FCF Margin
-98.94%9.89%14.51%45.06%-18872.00%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22
P/FCF Ratio
-130.88---
PS Ratio
15.7012.94---